Response to Comment on "Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin-Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study"

Pharmacotherapy. 2025 Sep;45(9):623-624. doi: 10.1002/phar.70054. Epub 2025 Aug 7.

Keisuke Mine^{1

2}, Takehiro Kawashiri¹, Yusuke Mori¹, Shunsuke Fujita¹, Mayako Uchida³, Takaaki Yamada^{3

4}, Nobuaki Egashira^{3

4}, Ichiro Ieiri^{3

5}, Satoru Koyanagi², Shigehiro Ohdo², Takao Shimazoe¹, Daisuke Kobayashi¹

¹ Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
² Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
³ Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan.
⁴ School of Pharmaceutical Sciences, Wakayama Medical University, Wakayama, Japan.
⁵ School of Pharmacy at Fukuoka, International University of Health and Welfare, Fukuoka, Japan.

No abstract available

Publication types